GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » Market Cap

Diva Laboratories (ROCO:4153) Market Cap : NT$2,291.0 Mil (As of Jun. 09, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Diva Laboratories's share price for the quarter that ended in Mar. 2024 was NT$39.15. Diva Laboratories's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 58.7 Mil. Therefore, Diva Laboratories's market cap for the quarter that ended in Mar. 2024 was NT$2,296.9 Mil.

Diva Laboratories's quarterly market cap declined from Jun. 2023 (NT$2,464.1 Mil) to Sep. 2023 (NT$1,965.4 Mil) but then increased from Sep. 2023 (NT$1,965.4 Mil) to Mar. 2024 (NT$2,296.9 Mil).

Diva Laboratories's annual market cap increased from Dec. 2020 (NT$1,455.0 Mil) to Dec. 2021 (NT$1,572.3 Mil) and increased from Dec. 2021 (NT$1,572.3 Mil) to Dec. 2022 (NT$2,379.0 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Diva Laboratories's Enterprise Value for Today is NT$1,712.5 Mil.


Diva Laboratories Market Cap Historical Data

The historical data trend for Diva Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories Market Cap Chart

Diva Laboratories Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,247.37 2,128.39 1,454.97 1,572.30 2,378.99

Diva Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,378.99 2,731.00 2,464.06 1,965.38 2,296.85

Competitive Comparison of Diva Laboratories's Market Cap

For the Diagnostics & Research subindustry, Diva Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diva Laboratories's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diva Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Diva Laboratories's Market Cap falls into.



Diva Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Diva Laboratories's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=NT$40.55*58.668
=NT$2,379.0

Diva Laboratories's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=NT$39.15*58.668
=NT$2,296.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diva Laboratories  (ROCO:4153) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Diva Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Diva Laboratories (ROCO:4153) Business Description

Traded in Other Exchanges
N/A
Address
9F, No. 351 Sector 2, Chung Shan Road, Chung Ho, New Taipei City, TWN, 235
Diva Laboratories Ltd is a Taiwan-based company that engages in the manufacturing and sale of a medical display. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories (ROCO:4153) Headlines

No Headlines